VMP 39109211000001100

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Co-careldopa 50mg/200mg modified-release tablets
BNF code 0409010N0AAAEAE
Virtual Therapeutic Moiety Co-careldopa
Date identifier became valid 21 Oct 2020
Previous product identifier 377267002
Basis of preferred name BAN - British Approved Name
Date of name applicability 4 May 2004
Previous name Co-careldopa 50/200 modified-release tablets
Basis of previous name BAN - British Approved Name
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Carbidopa monohydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 73579000
Strength value numerator 50.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Levodopa
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 200.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletmodified-release.oral
Dose Form
Formulation Modified-release tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Lecado 200mg/50mg modified-release tablets (Sandoz Ltd)
Sinemet CR 50mg/200mg tablets (Organon Pharma (UK) Ltd)
Virtual Medicinal Product Packs
Co-careldopa 50mg/200mg modified-release tablets 30 tablet
Co-careldopa 50mg/200mg modified-release tablets 50 tablet
Co-careldopa 50mg/200mg modified-release tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback